Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at Citi's 2024...

Key Takeaway: Haemonetics Corporation announced that its President and CEO, Chris Simon, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on February 29, 2024. The event will be accessible via a live webcast, with a replay available afterward. This engagement highlights Haemonetics' commitment to investor relations and transparency.
Price reaction · baseline $71.43 (2024-02-20 close) · hit after-hours · clean, no other HAE news in the window
day 0 close · peak
+2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics is actively engaging with investors.
  • The event provides a platform for discussing innovative medical solutions.
  • Live webcast accessibility enhances transparency and investor relations.

Full Press Release Details

BOSTON , Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at 8:45 a.m. ET .
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://kvgo.com/unplugged-medtech-life-sciences-access-day/haemonetics-corp-feb-2024 . A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
About Haemonetics
Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When will Haemonetics present at Citi's event?

Haemonetics will present on February 29, 2024, at 8:45 a.m. ET.

How can I access the Haemonetics presentation?

The presentation will be available via a live webcast on Haemonetics' Investor Relations website.

Will there be a replay of the presentation?

Yes, a replay will be available 12 hours after the event for 90 days.

Who is the speaker at the Citi event?

Chris Simon, President and CEO of Haemonetics, will be the speaker.

Last updated: Feb 21, 2024